Factors associated with severity of daytime sleepiness and indications for initiating treatment in patients with periodic limb movements during sleep

Keisuke Sakuta, Yoko Komada, Tatsuo Kagimura, Isa Okajima, Masaki Nakamura, Yuichi Inoue

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Determinations of subjective daytime sleepiness among patients with periodic limb movements during sleep (PLMS), and of the cut-off level of periodic limb movement index (PLMI) for starting treatment have been inconclusive. This retrospective study was set out to clarify these issues by investigating the relationship between subjective sleepiness measure and PLMI as well as other demographic variables both before and after starting the treatment. Firstly, we investigated factors associated with excessive daytime sleepiness (Epworth sleepiness scale: ESS ≥ 11) in untreated 74 PLMS patients (42 men, 32 women) using multiple logistic regression analysis. Secondly, in 34 patients treated with pramipexole (PPX), a dopamine agonist, the cut-off PLMI for predicting treatment effectiveness on subjective sleepiness (≥median reduction rate of ESS: 18%) was evaluated using the receiver operating characteristic (ROC) curve. As a result, PLMI and age positively correlated (r = 0.46, P < 0.0001), but age showed very small but significantly negative correlation with excessive daytime sleepiness (odds ratio = 0.96, 95% confidence interval = 0.93-0.99, P < 0.05) in untreated PLMS patients. Moreover, the optimal cut-off PLMI for predicting a substantial improvement in subjective daytime sleepiness was 31.35/h on ROC analysis among the patients who received the treatment with PPX. Although clear relationship between PLMI and subjective sleepiness severity was not observed, the present study indicated that a PLMI ≥ 31.35/h may become an indication for starting treatment so as to improve daytime sleepiness.

Original languageEnglish
Pages (from-to)187-194
Number of pages8
JournalSleep and Biological Rhythms
Volume10
Issue number3
DOIs
Publication statusPublished - 2012 Jul
Externally publishedYes

Fingerprint

Sleep
Extremities
Therapeutics
ROC Curve
Dopamine Agonists
Retrospective Studies
Logistic Models
Odds Ratio
Regression Analysis
Demography
Confidence Intervals

Keywords

  • Aging
  • Dopamine agonist
  • Epworth sleepiness scale
  • Excessive daytime sleepiness
  • Periodic limb movements during sleep
  • Pramipexole
  • Treatment

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Neurology
  • Neuropsychology and Physiological Psychology

Cite this

Factors associated with severity of daytime sleepiness and indications for initiating treatment in patients with periodic limb movements during sleep. / Sakuta, Keisuke; Komada, Yoko; Kagimura, Tatsuo; Okajima, Isa; Nakamura, Masaki; Inoue, Yuichi.

In: Sleep and Biological Rhythms, Vol. 10, No. 3, 07.2012, p. 187-194.

Research output: Contribution to journalArticle

Sakuta, Keisuke ; Komada, Yoko ; Kagimura, Tatsuo ; Okajima, Isa ; Nakamura, Masaki ; Inoue, Yuichi. / Factors associated with severity of daytime sleepiness and indications for initiating treatment in patients with periodic limb movements during sleep. In: Sleep and Biological Rhythms. 2012 ; Vol. 10, No. 3. pp. 187-194.
@article{6e0edb5cc36349ce87cef20cccc1c2f3,
title = "Factors associated with severity of daytime sleepiness and indications for initiating treatment in patients with periodic limb movements during sleep",
abstract = "Determinations of subjective daytime sleepiness among patients with periodic limb movements during sleep (PLMS), and of the cut-off level of periodic limb movement index (PLMI) for starting treatment have been inconclusive. This retrospective study was set out to clarify these issues by investigating the relationship between subjective sleepiness measure and PLMI as well as other demographic variables both before and after starting the treatment. Firstly, we investigated factors associated with excessive daytime sleepiness (Epworth sleepiness scale: ESS ≥ 11) in untreated 74 PLMS patients (42 men, 32 women) using multiple logistic regression analysis. Secondly, in 34 patients treated with pramipexole (PPX), a dopamine agonist, the cut-off PLMI for predicting treatment effectiveness on subjective sleepiness (≥median reduction rate of ESS: 18{\%}) was evaluated using the receiver operating characteristic (ROC) curve. As a result, PLMI and age positively correlated (r = 0.46, P < 0.0001), but age showed very small but significantly negative correlation with excessive daytime sleepiness (odds ratio = 0.96, 95{\%} confidence interval = 0.93-0.99, P < 0.05) in untreated PLMS patients. Moreover, the optimal cut-off PLMI for predicting a substantial improvement in subjective daytime sleepiness was 31.35/h on ROC analysis among the patients who received the treatment with PPX. Although clear relationship between PLMI and subjective sleepiness severity was not observed, the present study indicated that a PLMI ≥ 31.35/h may become an indication for starting treatment so as to improve daytime sleepiness.",
keywords = "Aging, Dopamine agonist, Epworth sleepiness scale, Excessive daytime sleepiness, Periodic limb movements during sleep, Pramipexole, Treatment",
author = "Keisuke Sakuta and Yoko Komada and Tatsuo Kagimura and Isa Okajima and Masaki Nakamura and Yuichi Inoue",
year = "2012",
month = "7",
doi = "10.1111/j.1479-8425.2012.00560.x",
language = "English",
volume = "10",
pages = "187--194",
journal = "Sleep and Biological Rhythms",
issn = "1446-9235",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Factors associated with severity of daytime sleepiness and indications for initiating treatment in patients with periodic limb movements during sleep

AU - Sakuta, Keisuke

AU - Komada, Yoko

AU - Kagimura, Tatsuo

AU - Okajima, Isa

AU - Nakamura, Masaki

AU - Inoue, Yuichi

PY - 2012/7

Y1 - 2012/7

N2 - Determinations of subjective daytime sleepiness among patients with periodic limb movements during sleep (PLMS), and of the cut-off level of periodic limb movement index (PLMI) for starting treatment have been inconclusive. This retrospective study was set out to clarify these issues by investigating the relationship between subjective sleepiness measure and PLMI as well as other demographic variables both before and after starting the treatment. Firstly, we investigated factors associated with excessive daytime sleepiness (Epworth sleepiness scale: ESS ≥ 11) in untreated 74 PLMS patients (42 men, 32 women) using multiple logistic regression analysis. Secondly, in 34 patients treated with pramipexole (PPX), a dopamine agonist, the cut-off PLMI for predicting treatment effectiveness on subjective sleepiness (≥median reduction rate of ESS: 18%) was evaluated using the receiver operating characteristic (ROC) curve. As a result, PLMI and age positively correlated (r = 0.46, P < 0.0001), but age showed very small but significantly negative correlation with excessive daytime sleepiness (odds ratio = 0.96, 95% confidence interval = 0.93-0.99, P < 0.05) in untreated PLMS patients. Moreover, the optimal cut-off PLMI for predicting a substantial improvement in subjective daytime sleepiness was 31.35/h on ROC analysis among the patients who received the treatment with PPX. Although clear relationship between PLMI and subjective sleepiness severity was not observed, the present study indicated that a PLMI ≥ 31.35/h may become an indication for starting treatment so as to improve daytime sleepiness.

AB - Determinations of subjective daytime sleepiness among patients with periodic limb movements during sleep (PLMS), and of the cut-off level of periodic limb movement index (PLMI) for starting treatment have been inconclusive. This retrospective study was set out to clarify these issues by investigating the relationship between subjective sleepiness measure and PLMI as well as other demographic variables both before and after starting the treatment. Firstly, we investigated factors associated with excessive daytime sleepiness (Epworth sleepiness scale: ESS ≥ 11) in untreated 74 PLMS patients (42 men, 32 women) using multiple logistic regression analysis. Secondly, in 34 patients treated with pramipexole (PPX), a dopamine agonist, the cut-off PLMI for predicting treatment effectiveness on subjective sleepiness (≥median reduction rate of ESS: 18%) was evaluated using the receiver operating characteristic (ROC) curve. As a result, PLMI and age positively correlated (r = 0.46, P < 0.0001), but age showed very small but significantly negative correlation with excessive daytime sleepiness (odds ratio = 0.96, 95% confidence interval = 0.93-0.99, P < 0.05) in untreated PLMS patients. Moreover, the optimal cut-off PLMI for predicting a substantial improvement in subjective daytime sleepiness was 31.35/h on ROC analysis among the patients who received the treatment with PPX. Although clear relationship between PLMI and subjective sleepiness severity was not observed, the present study indicated that a PLMI ≥ 31.35/h may become an indication for starting treatment so as to improve daytime sleepiness.

KW - Aging

KW - Dopamine agonist

KW - Epworth sleepiness scale

KW - Excessive daytime sleepiness

KW - Periodic limb movements during sleep

KW - Pramipexole

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84863876775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863876775&partnerID=8YFLogxK

U2 - 10.1111/j.1479-8425.2012.00560.x

DO - 10.1111/j.1479-8425.2012.00560.x

M3 - Article

AN - SCOPUS:84863876775

VL - 10

SP - 187

EP - 194

JO - Sleep and Biological Rhythms

JF - Sleep and Biological Rhythms

SN - 1446-9235

IS - 3

ER -